AXGN Q2 2022 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$34M+2.6% YoY

Gross Profit

$28M81.8% margin

Operating Income

-$8M-23.0% margin

Net Income

-$8M-22.5% margin

EPS (Diluted)

$-0.18

QoQ Revenue Growth

+11.1%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$10M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$196M

Total Liabilities

$94M

Stockholders' Equity

$102M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$34M	$34M	+2.6%
Gross Profit	$28M	$26M	+6.4%
Operating Income	-$8M	-$7M	-10.8%
Net Income	-$8M	-$8M	+2.0%